Dr. James Neel, MD
What this data tells you about Dr. Neel
Dr. James Neel is a hematology in Melbourne, FL, with 20 years in practice. Based on federal Medicare data, Dr. Neel performed 96,734 Medicare services across 2,595 unique beneficiaries.
Between the years covered by Open Payments, Dr. Neel received a total of $706 from 14 pharmaceutical and/or device companies across 38 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Neel is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Injectafer) | 20,250 | $1 | $3 |
| Anti-nausea injection (fosaprepitant) | 16,200 | $0 | $4 |
| Pembrolizumab injection (Keytruda) | 13,200 | $43 | $105 |
| Paclitaxel chemotherapy injection | 8,890 | $0 | $1 |
| Oxaliplatin chemotherapy injection | 6,590 | $0 | $1 |
| Denosumab injection (Prolia/Xgeva) | 5,700 | $18 | $45 |
| Epoetin alfa injection (Retacrit) for anemia | 5,262 | $6 | $22 |
| Iron sucrose injection (Venofer) | 3,900 | $0 | $1 |
| Immune globulin infusion (Gammagard) | 2,610 | $36 | $90 |
| Dexamethasone injection (steroid) | 2,360 | $0 | $0 |
| Abatacept infusion (Orencia) | 2,050 | $31 | $102 |
| Anti-nausea injection (Aloxi/palonosetron) | 1,130 | $1 | $30 |
| Injection, rituximab-pvvr, biosimilar, (ruxience), 10 mg | 880 | $22 | $142 |
| Injection, fulvestrant, 25 mg | 620 | $7 | $173 |
| Office visit, established patient (30-39 min) | 604 | $89 | $255 |
| Anti-nausea injection (ondansetron/Zofran) | 508 | $0 | $0 |
| Injection, granisetron hydrochloride, 100 mcg | 490 | $0 | $3 |
| Injection, leucovorin calcium, per 50 mg | 457 | $3 | $8 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 448 | $21 | $57 |
| Administration of chemotherapy into vein, 1 hour or less | 435 | $93 | $255 |
| Drug injection, under skin or into muscle | 362 | $11 | $42 |
| Injection, carboplatin, 50 mg | 345 | $2 | $36 |
| Injection, fluorouracil, 500 mg | 327 | $2 | $6 |
| Hospital follow-up visit, high complexity | 322 | $91 | $236 |
| Office visit, established patient (20-29 min) | 292 | $60 | $180 |
| Injection of additional new drug or substance into vein | 275 | $11 | $36 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 232 | $47 | $135 |
| Office visit, established patient, complex (40-54 min) | 168 | $133 | $358 |
| Injection, diphenhydramine hcl, up to 50 mg | 160 | $1 | $3 |
| Administration of chemotherapy into vein, each additional hour | 146 | $21 | $55 |
| Collection of blood sample from implanted device | 139 | $19 | $52 |
| Infusion, normal saline solution , 1000 cc | 122 | $2 | $6 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 114 | $134 | $1,090 |
| Administration of additional new drug or substance into vein, 1 hour or less | 112 | $48 | $126 |
| Infusion into a vein for hydration, 31-60 minutes | 102 | $24 | $96 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 96 | $23 | $66 |
| Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | 80 | $16 | $40 |
| Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 75 | $54 | $142 |
| Injection, zoledronic acid, 1 mg | 73 | $7 | $25 |
| Hospital follow-up visit, moderate complexity | 72 | $58 | $158 |
| Infusion into a vein for hydration, each additional hour | 71 | $10 | $25 |
| Initial hospital admission, moderate complexity | 57 | $103 | $265 |
| Red blood cells, leukocytes reduced, each unit | 50 | $57 | $564 |
| Administration of additional new drug or substance into vein using push technique | 48 | $41 | $109 |
| Transfusion of blood or blood products | 44 | $30 | $76 |
| Initial hospital admission, high complexity | 41 | $137 | $354 |
| Irrigation of implanted venous access drug delivery device | 36 | $17 | $50 |
| Injection, methylprednisolone sodium succinate, up to 125 mg | 32 | $4 | $12 |
| Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion | 30 | $15 | $39 |
| Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l | 30 | $130 | $317 |
| Injection of drug or substance into vein | 27 | $27 | $91 |
| Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | 25 | $1 | $5 |
| Drawing of blood for a medical problem | 23 | $67 | $189 |
| New patient office visit (30-44 min) | 22 | $68 | $225 |
Industry Payment Transparency
Open Payments through 2023 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2023)
Associated products mentioned in payments ›
Most payments (77%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2023 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Neel is a mixed practice specialist, with moderate Medicare volume, and low-engagement industry engagement, with 20 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Neel experienced with iron infusion (injectafer)?
Does Dr. Neel receive payments from pharmaceutical companies?
How do Dr. Neel's costs compare to other hematologys in Melbourne?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology